UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

045 - PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE

Leukemia research, 2022-10, Vol.121, p.S32-S32

2022

Volltextzugriff (PDF)

1. L’architecture

1990

Volltextzugriff (PDF)

1. Le site archéologique

1990

Volltextzugriff (PDF)

10-year review of prosthetic treatment of a case of hypohidrotic ectodermal dysplasia

Revista europea de odonto-estomatologia, 1991-07, Vol.3 (4), p.247

1991

Volltextzugriff (PDF)

1046 Sorafenib Inhibits Cell Migration and Stroma-mediated Bortezomib Resistance by Interfering BCR Signaling and Protein Translation in Mantle Cell Lymphoma

European journal of cancer (1990), 2012-07, Vol.48, p.S252-S252

2012

Volltextzugriff (PDF)

114P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Long-term efficacy and safety analysis of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

ESMO open, 2024-05, Vol.9, p.103102, Article 103102

2024

Volltextzugriff (PDF)

117 Vorinostat induces acetylation of BH3-only gene promoters triggering their expression and leading to apoptosis in mantle cell lymphoma

European journal of cancer supplements, 2010, Vol.8 (7), p.44-44

2010

Volltextzugriff (PDF)

166 BAY 43-9006/Sorafenib overcomes the protective effect of stroma and synergizes with the BH3-mimetic GX15–070/Obatoclax in chronic lymphocytic leukemia cells

European journal of cancer supplements, 2010, Vol.8 (7), p.57-58

2010

Volltextzugriff (PDF)

1756P Cancer patients infected with COVID-19 at La Princesa Hospital: Real-world data study

Annals of oncology, 2020-09, Vol.31, p.S1023-S1023

2020

Volltextzugriff (PDF)

195 Molecular bases of everolimus antiproliferative activity in mantle cell lymphoma

European journal of cancer supplements, 2010, Vol.8 (7), p.65-65

2010

Volltextzugriff (PDF)

208 - Clinical and Biological Significance of Y Chromosome Loss in a Series of 2,423 Male Patients with MDS and CMML

Leukemia research, 2017-04, Vol.55, p.S122-S123

2017

Volltextzugriff (PDF)

2105 POSTER An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations

European journal of cancer supplements, 2007, Vol.5 (4), p.215-215

2007

Volltextzugriff (PDF)

213P Constructing a high-definition patient-digital twin (PDT) in treatment-naïve women with advanced cancer

Annals of oncology, 2024-09, Vol.35, p.S301-S301

2024

Volltextzugriff (PDF)

269 Molecular interplay between cancer cell fatty acid metabolism and oncogenic signaling as resource for novel treatment strategies against ovarian cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S49-S49

2015

Volltextzugriff (PDF)

28 SiO v = 0 J = 1–0 emission from evolved stars

Astronomy and astrophysics (Berlin), 2016-05, Vol.589, p.A74

2016

Volltextzugriff (PDF)

28P CHKB muscular dystrophy: beyond megamitochondria

Neuromuscular disorders : NMD, 2024-10, Vol.43

2024

Volltextzugriff (PDF)

28SiO v = 0 J = 1–0 emission from evolved stars

Astronomy and astrophysics (Berlin), 2016, Vol.589

2016

Volltextzugriff (PDF)

28SiO v = 1 and v = 2, J = 1-0 maser variability in evolved stars. Eleven years of short spaced monitoring

Astronomy and astrophysics (Berlin), 2004, Vol.424 (1), p.145-156

2004

Volltextzugriff (PDF)

333 Myc/p27 Balance in Chronic Lymphocytic Leukemia

European journal of cancer (1990), 2012-07, Vol.48, p.S81-S81

2012

Volltextzugriff (PDF)

3D Assessment of Lymph Nodes vs. RECIST 1.1

Academic radiology, 2011-03, Vol.18 (3), p.391-394

2011

Volltextzugriff (PDF)

43O Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial

Annals of oncology, 2021-05, Vol.32, p.S38-S39

2021

Volltextzugriff (PDF)

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study

Muscle & nerve, 2013-09, Vol.48 (3), p.357-368

2013

Volltextzugriff (PDF)

THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study

Muscle & nerve, 2013-09, Vol.48 (3), p.343-356

2013

Volltextzugriff (PDF)

6006 ORAL DNA repair gene ATM polymorphisms and risk of chronic lymphocytic leukaemia

European journal of cancer supplements, 2007, Vol.5 (4), p.347-347

2007

Volltextzugriff (PDF)

1 – 25 von 838

Suche als RSS-Feed

Aktive Filter

KollektionJstor Complete Legacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(734)
Mit Volltextzugriff
(709)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(354)
Humans
(280)
Life Sciences & Biomedicine
(268)
Female
(171)
Male
(161)
Biological And Medical Sciences
(134)
Middle Aged
(126)
Medical Sciences
(124)
Adult
(111)
Aged
(89)
Hematology
(80)
Oncology
(77)
Hematologic And Hematopoietic Diseases
(69)
Physical Sciences
(62)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(61)
Physics
(53)
Adolescent
(46)
Technology
(44)
Aged, 80 And Over
(40)
Spain
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

045 - PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE

1. L’architecture

1. Le site archéologique

10-year review of prosthetic treatment of a case of hypohidrotic ectodermal dysplasia

1046 Sorafenib Inhibits Cell Migration and Stroma-mediated Bortezomib Resistance by Interfering BCR Signaling and Protein Translation in Mantle Cell Lymphoma

114P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Long-term efficacy and safety analysis of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

117 Vorinostat induces acetylation of BH3-only gene promoters triggering their expression and leading to apoptosis in mantle cell lymphoma

166 BAY 43-9006/Sorafenib overcomes the protective effect of stroma and synergizes with the BH3-mimetic GX15–070/Obatoclax in chronic lymphocytic leukemia cells

1756P Cancer patients infected with COVID-19 at La Princesa Hospital: Real-world data study

195 Molecular bases of everolimus antiproliferative activity in mantle cell lymphoma

208 - Clinical and Biological Significance of Y Chromosome Loss in a Series of 2,423 Male Patients with MDS and CMML

2105 POSTER An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations

213P Constructing a high-definition patient-digital twin (PDT) in treatment-naïve women with advanced cancer

269 Molecular interplay between cancer cell fatty acid metabolism and oncogenic signaling as resource for novel treatment strategies against ovarian cancer

28 SiO v = 0 J = 1–0 emission from evolved stars

28P CHKB muscular dystrophy: beyond megamitochondria

28SiO v = 0 J = 1–0 emission from evolved stars

28SiO v = 1 and v = 2, J = 1-0 maser variability in evolved stars. Eleven years of short spaced monitoring

333 Myc/p27 Balance in Chronic Lymphocytic Leukemia

3D Assessment of Lymph Nodes vs. RECIST 1.1

43O Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial

46P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study

THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study

6006 ORAL DNA repair gene ATM polymorphisms and risk of chronic lymphocytic leukaemia

Aktive Filter

Suchergebnisse filtern